The FDA has placed clinical holds on three trials run by Zentalis Pharmaceuticals after two study participants died, the biopharmaceutical company said June 18.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Cancer therapy trials paused after 2 deaths
